Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Comment by deninsaskon Sep 07, 2007 2:28pm
185 Views
Post# 13358373

RE: RBC Report

RE: RBC Report Reiterate that Transition extending the deadline is a Positive with a Capital Peeeeeeee! Novo ain't just looking at the positive E1-INT Results. The G1 Phasel's were astoundingly good. Good enough to earn G1 its Own Phasell no less.........and NO side effects. Nil Nada None Dick. Novo conducted their own Phasel on G1 so they have a heightened awareness of the stakes here!! Very high stakes indeed!
Bullboard Posts